Maternal Fatigue After Postpartum Anemia Treatment With Intravenous Ferric Carboxymaltose and Oral Iron Therapy

Postpartum Anemia is common after childbirth and may contribute to tiredness and reduced wellbeing in mothers.This randomized controlled trial will compare two treatments for postpartum iron deficiency:intravenous ferric carboxymaltose and oral iron therapy .This study will assess whether intravenous ferric carboxymaltose provides greater improvement in maternal fatigue during the first 6 weeks after childbirth compared to oral iron.Secondary outcomes will be assessment of depressive symptoms and breastfeeding self efficacy .Eligible postpartum women with iron deficiency anemia will be randomly assigned to receive either intravenous ferric carboxymaltose or oral iron therapy and will be followed for six weeks.The study hypothesis is that intravenous ferric carboxymaltose will result in greater improvement in maternalfatigue and may also effect breastfeeding self efficacy .

Inclusion criteria * Women aged 18-45 years * Postpartum period (within 48 hours) * Hemoglobin \< 10 g/dL * Singleton delivery * Willing to participate Exclusion Criteria * Severe anemia requiring blood transfusion * Known hemoglobinopathies * Chronic medical illness (renal, hepatic, cardiac) * Postpartum sepsis or PPH * Previous iron therapy in current pregnancy